GL1X · GenesisL1 explorer

MolNFT v1 · #165508 · protein

Human aldose reductase mutant L300A in complex with a ligand with an idd structure (3-({[2-(carboxymethoxy)-4-FLUOROBENZOYL]AMINO}METHYL) benzoic acid)

6TXP · Aldo-keto reductase family 1 member B1: “Human aldose reductase mutant L300A in complex with a ligand with an idd structure…”. X-ray diffraction, 2 ligands (4G7, NAP), 1 pocket (best druggability 0.70). MolNFT v1 #165508 on…

PDB
6TXP
Type
protein
Length
316 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Aldo-keto reductase family 1 member B1
EC
1.1.1.300, 1.1.1.372, 1.1.1.54, 1.1.1.21
UniProt
P15121
Ligands
4G7, NAP
Pockets
1 · best druggability 0.70

Structure

x-ray diffraction · 1 distinct chain · 38% helix, 15% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AAldo-keto reductase family 1 member B1 (EC 1.1.1.300, 1.1.1.372, 1.1.1.54, 1.1.1.21)protein31638% helix, 15% strandP15121

Ligands and binding sites

  • 4G7 · 3-({[2-(carboxymethoxy)-4-fluorobenzoyl]amino}methyl) benzoic acid · ligand · 2 copies · chains A
  • NAP · Nadp nicotinamide-adenine-dinucleotide phosphate · ligand · chains A
  • CIT · Citric acid · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13160.700.83494G7, NAP

Compared structures

  • 6TXP · Human Aldose Reductase Mutant L300A in Complex with a Ligand with an IDD Structure… · the same entry in another collection · chain A against A, TM-score 1.00
  • P15121 · AlphaFold monomer V2.0 prediction for aldo-keto reductase family 1 member B1 (P15121) · a predicted model of the same protein · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.